AxoGen (GB:0HKD)

AxoGen (0HKD) Share Price & Analysis


0HKD Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$8.06 - $13.19
Previous Close$8.48
Average Volume (3M)173.00
Market Cap
Enterprise Value$378.13M
Total Cash (Recent Filing)$37.87M
Total Debt (Recent Filing)$45.93M
Price to Earnings (P/E)-14.6
Aug 02, 2023
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding42,832,050
10 Day Avg. Volume1
30 Day Avg. Volume173
Standard Deviation0.18
Financial Highlights & Ratios
Price to Book (P/B)3.74
Price to Sales (P/S)23.23
Price to Cash Flow (P/CF)66.80
P/FCF Ratio64.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.62
Enterprise Value/Gross Profit3.30
Enterprise Value/Ebitda-19.28
Price Target Upside88.61% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4




What was AxoGen’s price range in the past 12 months?
AxoGen lowest share price was $8.06 and its highest was $13.19 in the past 12 months.
    What is AxoGen’s market cap?
    Currently, no data Available
    When is AxoGen’s upcoming earnings report date?
    AxoGen’s upcoming earnings report date is Aug 02, 2023 which is in 59 days.
      How were AxoGen’s earnings last quarter?
      AxoGen released its earnings results on May 09, 2023. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.142 by $0.042.
        Is AxoGen overvalued?
        According to Wall Street analysts AxoGen’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does AxoGen pay dividends?
          AxoGen pays a Notavailable dividend of $1 which represents an annual dividend yield of N/A. See more information on AxoGen dividends here
            What is AxoGen’s EPS estimate?
            AxoGen’s EPS estimate is -$0.12.
              How many shares outstanding does AxoGen have?
              AxoGen has 42,832,050 shares outstanding.
                What happened to AxoGen’s price movement after its last earnings report?
                AxoGen reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.142. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of AxoGen?
                  Among the largest hedge funds holding AxoGen’s share is Perceptive Advisors LLC. It holds AxoGen’s shares valued at 13M.


                    AxoGen Stock Smart Score

                    The AxoGen Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description


                    AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.


                    Forecast EPS vs Actual EPS

                    Similar Stocks
                    Price & Change
                    Axsome Therapeutics
                    Corvus Pharmaceuticals
                    Eton Pharmaceuticals

                    Popular Stocks

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis